DFFVX
Price
$34.03
Change
-$0.45 (-1.31%)
Updated
Sep 20 closing price
TNVCX
Price
$17.90
Change
-$0.18 (-1.00%)
Updated
Sep 20 closing price
Ad is loading...

DFFVX vs TNVCX

Header iconDFFVX vs TNVCX Comparison
Open Charts DFFVX vs TNVCXBanner chart's image
DFA US Targeted Value I
Price$34.03
Change-$0.45 (-1.31%)
VolumeN/A
CapitalizationN/A
1290 GAMCO Small/Mid Cap Value T
Price$17.90
Change-$0.18 (-1.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DFFVX vs TNVCX Comparison Chart
Loading...
VS
DFFVX vs. TNVCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and TNVCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.8B vs. TNVCX (160M). DFFVX pays higher dividends than TNVCX: DFFVX (1.37) vs TNVCX (0.80). DFFVX was incepted earlier than TNVCX: DFFVX (25 years) vs TNVCX (10 years). DFFVX is a more actively managed with annual turnover of: 20.00 vs. TNVCX (14.00). DFFVX has a lower initial minimum investment than TNVCX: DFFVX (0) vs TNVCX (1000). DFFVX annual gain was more profitable for investors over the last year : 22.61 vs. TNVCX (16.79). DFFVX return over 5 years is better than : 59.42 vs. TNVCX (49.35).
DFFVXTNVCXDFFVX / TNVCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years10 years-
Gain YTD7.5148.99484%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.8B160M8,625%
Annual Yield % from dividends1.370.80171%
Returns for 1 year22.6116.79135%
Returns for 3 years20.0313.53148%
Returns for 5 years59.4249.35120%
Returns for 10 years55.75N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDIO0.28N/A
+1.54%
Cardio Diagnostics Holdings
EARN7.01N/A
N/A
Ellington Credit Company
TFII145.35-4.43
-2.96%
TFI International
EXAI5.04-0.16
-3.08%
Exscientia Plc
EWTX28.26-1.24
-4.20%
Edgewise Therapeutics